Literature DB >> 17346761

Expression and characterization of a recombinant fibrinogenolytic serine protease from green pit viper (Trimeresurus albolabris) venom.

Chuanchom Muanpasitporn1, Ponlapat Rojnuckarin.   

Abstract

Viper venom serine proteases (SPs) display several effects on hemostatic system. Molecular cloning showed that Trimeresurus albolabris venom comprised a mixture of five SPs with thrombin-like (2), fibrinogenase (2) and plasminogen-activating (1) activities. Because only few fibrinogenolytic SP sequences were reported, we decided to express albofibrase, a novel fibrinogenase from T. albolabris using Pichia pastoris system. The recombinant active form of enzyme was 30 kDa including 2.2 kDa of glycosylation. Albofibrase showed an alpha fibrinogenase activity. In addition, a plasminogen activating and clotting effect were detectable. Albofibrase prolonged APTT and PT in a time-dependent manner. The effect was neutralized by pre-incubation with equine antivenom to T. albolabris. Therefore, the protein is potentially useful as a new anticoagulant as the antidote is clinically available. Sequence analysis compared with other snake venom fibrinogenases and SPs could not find any unique residues responsible for their various effects. Structure-function relationship should be further studied using mutagenesis in order to explore the mechanisms of venom protease functional diversity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346761     DOI: 10.1016/j.toxicon.2007.01.015

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  2 in total

1.  A novel serine protease from the snake venom of Agkistrodon blomhoffii ussurensis.

Authors:  Shuqing Liu; Ming-Zhong Sun; Changkai Sun; Baochang Zhao; Frederick T Greenaway; Qingyin Zheng
Journal:  Toxicon       Date:  2008-09-09       Impact factor: 3.033

2.  Purification and functional characterisation of rhinocerase, a novel serine protease from the venom of Bitis gabonica rhinoceros.

Authors:  Sakthivel Vaiyapuri; Robert A Harrison; Andrew B Bicknell; Jonathan M Gibbins; Gail Hutchinson
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.